Moteur de recherche d’entreprises européennes
Rapport annuel Rikf21/06/2013 Registrite ja Infosüsteemide Keskus (financials), Estonie
Vue d’ensemble
Texte
| Devise: EUR | ||
| Date | 2012-12-31 | 2011-12-31 |
| Cash flows from operating activities | 0.0 | 0.0 |
| -Operating profit (loss) / result from core activities | 117814.0 | 162954.0 |
| -Adjustments | 0.0 | 0.0 |
| -Depreciation and impairment of fixed assets | 15873.0 | 33427.0 |
| -Gain (loss) on sale of fixed assets | -9921.0 | -33772.0 |
| -Other adjustments | 0.0 | 0.0 |
| -Total adjustments | 5952.0 | -345.0 |
| -Change in receivables and prepayments related to operations | -14793.0 | 156711.0 |
| -Change in inventories | 0.0 | 0.0 |
| -Change in payables and advances related to operations | 110576.0 | 14194.0 |
| -Interest received | 0.0 | 0.0 |
| -Interest paid | 0.0 | 0.0 |
| -Corporate income tax paid | 0.0 | 0.0 |
| -Receipts from earmarked fees, donations, grants/subsidies | 0.0 | 0.0 |
| -Other cash flows from operating activities | 0.0 | 0.0 |
| -Dividends received | 0.0 | 0.0 |
| -Net cash from operating activities | 219549.0 | 333514.0 |
| Cash flows from investing activities | 0.0 | 0.0 |
| -Purchase of tangible and intangible fixed assets (cash paid) | -5630.0 | -10592.0 |
| -Proceeds from sale of tangible and intangible fixed assets | 17750.0 | 84808.0 |
| -Purchase of investment property (cash paid) | 0.0 | 0.0 |
| -Proceeds from sale of investment property | 0.0 | 0.0 |
| -Acquisition of subsidiaries (cash paid) | 0.0 | 0.0 |
| -Proceeds from sale of subsidiaries | 0.0 | 0.0 |
| -Acquisition of associates (cash paid) | 0.0 | 0.0 |
| -Proceeds from sale of associates | 0.0 | 0.0 |
| -Acquisition of other financial investments (cash paid) | 0.0 | 0.0 |
| -Proceeds from sale of other financial investments | 0.0 | 0.0 |
| -Loans granted | 0.0 | 0.0 |
| -Repayments of loans granted | 0.0 | 0.0 |
| -Interest received | 0.0 | 0.0 |
| -Dividends received | 0.0 | 0.0 |
| -Other payments from investing activities | 0.0 | 0.0 |
| -Other receipts from investing activities | 0.0 | 0.0 |
| -Net cash from investing activities | 13733.0 | 75771.0 |
| Cash flows from financing activities | 0.0 | 0.0 |
| -Loans received / borrowings | 0.0 | 0.0 |
| -Repayment of loans / borrowings repaid | 0.0 | 0.0 |
| -Change in overdraft / revolving credit balance | 0.0 | 0.0 |
| -Repayment of finance lease principal | 0.0 | 0.0 |
| -Interest paid | 0.0 | 0.0 |
| -Contributions to endowment / capital fund received | 0.0 | 0.0 |
| -Proceeds from issuing shares / equity interests | 0.0 | 0.0 |
| -Payments for repurchase of own shares/units | 0.0 | 0.0 |
| -Dividends paid | 0.0 | 0.0 |
| -Corporate income tax paid | 0.0 | 0.0 |
| -Other receipts from financing activities | 0.0 | 0.0 |
| -Other payments from financing activities | 0.0 | 0.0 |
| -Net cash from financing activities | 0.0 | -184.0 |
| Net cash flows (total) | 233282.0 | 409101.0 |
| -Cash and cash equivalents at beginning of period | 1114488.0 | 705387.0 |
| -Change in cash and cash equivalents | 233282.0 | 409101.0 |
| -Effect of exchange rate changes | 0.0 | 0.0 |
| -Cash and cash equivalents at end of period | 1347770.0 | 1114488.0 |
Cette annonce se réfère à une date antérieure et ne reflète pas nécessairement l’état actuel. L’état actuel est présenté à la page suivante : AstraZeneca Eesti OÜ, Tallinn, Estonie.